Residual Cancer Stem Cells after Interval Cytoreductive Surgery following Neoadjuvant Chemotherapy Could Result in Poor Treatment Outcomes for Ovarian Cancer

Publisher： Karger

E-ISSN： 2296-5262|33|6|324-330

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.6, 2010-05, pp. : 324-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy

By  

Oncology, Vol. 89, Iss. 3, 2015-05 ,pp. : 159-166

Karger

Access to resources Recommend Favorite

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 331-340

Karger

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Role of cytoreductive surgery in recurrent ovarian cancer

By Fagotti Anna   Gallotta Valerio   Romano Federico   Fanfani Francesco   Rossitto Cristiano   Vizzielli Giuseppe   Costantini Barbara   Scambia Giovanni  

Therapy, Vol. 7, Iss. 1, 2010-01 ,pp. : 87-95

Future Medicine

Access to resources Recommend Favorite

Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer with Incidental Bochdalek Hernia and Postoperative Bilateral Thalamic Infarct: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-03 ,pp. : 265-271

Karger

Access to resources Recommend Favorite